Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells - 14/03/12
Corresponding authors. Tel.: +86 25 83718836 6428; fax: +86 25 83710040.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Recent studies have indicated that side population (SP) cells, which are an enriched source of cancer stem cells (CSCs), drive and maintain many types of human malignancies. SP cells have distinguishing biological characteristics and are thought to contribute to metastasis, therapy resistance, and tumor recurrence. In the present study, the miRNA expression profiles of SP cells and non-SP cells were compared using miRNA array analysis. Both let-7 and miR-31 were significantly down-regulated in SP cells compared to non-SP cells. The results were confirmed by real-time PCR. Engineered repression of miR-31 caused marked repression of both lung cancer SP cell and non-SP cell growth in vitro. In contrast, engineered repression of let-7 caused marked promotion of both lung cancer SP and non-SP cells growth in vitro. Cell cycle studies further revealed that reduced miR-31 could inhibit SP cell proliferation by a cell cycle arrest in the G0/G1 phase, whereas reduced let-7 induced SP cell proliferation by accelerating G1/S phase transition. Notably, reduced miR-31 prevented SP cell differentiation, whereas reduced let-7 promoted SP cell differentiation under differentiation conditions. These findings indicate that reduced miR-31 and let-7 are involved in maintaining the balance between differentiation and quiescence in SP cells.
Le texte complet de cet article est disponible en PDF.Keywords : Expression profiling, Microarrays, Cancer stem cell, Side population cell, miRNA, Lung cancer, Tumor suppressive miRNA
Abbreviations : CSCs, DCC, DNC, ES cell, miRNA, SP
Plan
Vol 66 - N° 2
P. 89-97 - mars 2012 Retour au numéro
Article précédent
- Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice
- Jiaqing Shen, Jing Gao, Jing Zhang, Di Xiang, Xia Wang, Lan Qian, Jie Shen, Lijuan Yang, Shunying Zhu, Mingyuan Wu, Yan Yu, Wei Han, Xingpeng Wang
- Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro
- Yi Ding, WenXing Liu, ChengTao Lu, Jing Yang, YanRong Zhu, Ying Song, ZhongYing Ma, Lin Yang, YanYan Jia, AiDong Wen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?